Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin
- PMID: 8798456
- DOI: 10.1074/jbc.271.37.22796
Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin
Abstract
Treatment of SKBr3 human breast carcinoma cells with the benzoquinoid ansamycin, geldanamycin, rapidly depletes p185c-erbB-2 protein-tyrosine kinase. Loss of p185c-erbB-2 is initiated by disruption of a heteromeric complex between p185c-erbB-2 and the 94-kDa glucose-regulated protein, GRP94, to which geldanamycin binds avidly. Here we report that within minutes of exposure to geldanamycin, mature p185c-erbB-2 becomes polyubiquitinated. Treatment of cells with the specific proteasome proteolytic inhibitor, lactacystin, blocked geldanamycin-induced degradation of p185c-erbB-2 and enhanced the accumulation of polyubiquitinated p185c-erbB-2. Following geldanamycin and lactacystin treatment, a higher molecular weight form of p185c-erbB-2, which likely represents ubiquitin-p185c-erbB-2 conjugates, was detected by anti-p185c-erbB-2 immunoblotting. Nascent p185c-erbB-2 synthesized in the presence of geldanamycin is incompletely glycosylated and remains sequestered in the endoplasmic reticulum. While this immature form of the protein is not ubiquitinated in the presence of geldanamycin, its marked, drug-induced instability is nonetheless antagonized by lactacystin. Thus, the rapid depletion of mature p185c-erbB-2 caused by geldanamycin and the marked, drug-stimulated decrease in half-life of the newly synthesized protein are both mediated by the proteasome, although only the former phenomenon involves polyubiquitination.
Similar articles
-
Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.FEBS Lett. 1998 Jan 30;422(2):129-31. doi: 10.1016/s0014-5793(97)01612-8. FEBS Lett. 1998. PMID: 9489990
-
Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.Oncogene. 1997 Jun 12;14(23):2809-16. doi: 10.1038/sj.onc.1201120. Oncogene. 1997. PMID: 9190897
-
Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.J Biol Chem. 1998 Sep 18;273(38):24649-53. doi: 10.1074/jbc.273.38.24649. J Biol Chem. 1998. PMID: 9733761
-
[Ligand-induced polyubiquitination of receptor tyrosine kinases].Tanpakushitsu Kakusan Koso. 1997 Oct;42(14 Suppl):2284-90. Tanpakushitsu Kakusan Koso. 1997. PMID: 9366209 Review. Japanese. No abstract available.
-
Ubiquitin in chains.Trends Biochem Sci. 2000 Nov;25(11):544-8. doi: 10.1016/s0968-0004(00)01681-9. Trends Biochem Sci. 2000. PMID: 11084366 Review.
Cited by
-
The Role of HSP90 in Preserving the Integrity of Genomes Against Transposons Is Evolutionarily Conserved.Cells. 2021 May 4;10(5):1096. doi: 10.3390/cells10051096. Cells. 2021. PMID: 34064379 Free PMC article. Review.
-
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.Expert Opin Drug Discov. 2011 May;6(5):559-587. doi: 10.1517/17460441.2011.563296. Expert Opin Drug Discov. 2011. PMID: 22400044 Free PMC article.
-
Ganetespib: research and clinical development.Onco Targets Ther. 2015 Jul 24;8:1849-58. doi: 10.2147/OTT.S65804. eCollection 2015. Onco Targets Ther. 2015. PMID: 26244021 Free PMC article. Review.
-
Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.J Med Chem. 2006 Oct 19;49(21):6290-7. doi: 10.1021/jm060647f. J Med Chem. 2006. PMID: 17034135 Free PMC article.
-
Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex.Nature. 2006 Apr 20;440(7087):1013-7. doi: 10.1038/nature04716. Nature. 2006. PMID: 16625188 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous